FDA Issues Guidances on Trial Enrichment, Monitoring

Drug Industry Daily
A A
The FDA released two clinical-related guidances on Thursday for sponsors of drugs and biologics, on enrichment of clinical trials and on risk-based monitoring.

To View This Article:

Login

Subscribe To Drug Industry Daily